Complex and cross-border healthcare transactions are Linklaters‘ greatest strength in the healthcare and life sciences sector, and clients include global investors, healthcare holding companies, and tech leaders. The practice employs a depth of expertise across legal disciplines: Rupert Bellinghausen is well-versed in arbitration and commercial litigation and leads on damages claims and medical product liability litigation; corporate law specialist Timo Engelhardt leads on high-value M&A; Julia Schönbohm brings expertise in IP and TMT law to act on healthcare data protection matters; and Jana Hager is renowned for her work in regulatory product law, and also assists on transactions.
Legal 500 Editorial commentary
Key clients
- Asahi Group
- Asklepios Kliniken
- Bayer
- Beiersdorf
- BioVersys AG
- Brookfield
- Carlyle
- Fresenius SE & Co. KGaA
- GTCR LLC
- Igneo Infrastructure Partners
- Jacobs Holding AG
- Siemens Healthineers AG
Work highlights
Advised Siemens Healthineers on the acquisition of Advanced Accelerator Applications Molecular Imaging from Novartis.
Advised GTCR in the bidding process to acquire a majority stake in Stada Arzneimittel AG in a competitive sale process from its existing shareholders, Bain Capital and Cinven.
Advised Carlyle Global Credit on its strategic capital investment in Orifarm Group A/S.
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Other key lawyers
Rupert Bellinghausen; Timo Engelhardt; Tim Johansen-Roth; Julia Schonborn; Jana Hager